RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FORCONI F
Collezione AOU Città della Salute di Torino

Items : 6

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib. in Blood advances / Blood Adv. 2023 Jun 27;7(12):2794-2806. doi: 10.1182/bloodadvances.2022008821.

2023
AOU Città della Salute di Torino
AOU Novara

Österborg A; Walewska R; Pavlovsky C; Strugov V; Ysebaert L; Mulligan SP; Coscia M; Iyengar S; Frustaci AM; Jaksic O; Ringshausen I; Panayiotidis P; Forconi F; Marasca R; Tam CS; Stavroyianni N; Bödör C; Reda G; Bonello L; Trentin L; Gaidano G; Gandini F; Lyander A; Gellerbring A; Skaftason A; Foroughi-Asl H; Weström S; Pandzic T; Capasso A; et alii...

Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. in Leukemia / Leukemia. 2020 Jun;34(6):1721. doi: 10.1038/s41375-019-0680-9.

2020
AOU Città della Salute di Torino

Arruga F; Bracciamà V; Vitale N; Vaisitti T; Gizzi K; Yeomans A; Coscia M; D'Arena G; Gaidano G; Allan JN; Furman RR; Packham G; Forconi F; Deaglio S;

Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. in Leukemia / Leukemia. 2020 Feb;34(2):462-477. doi: 10.1038/s41375-019-0571-0. Epub 2019 Aug 29.

2020
AOU Città della Salute di Torino

Packham G; Furman RR; Allan JN; Gaidano G; D'Arena G; Coscia M; Yeomans A; Gizzi K; Vaisitti T; Vitale N; Bracciamà V; Arruga F; Forconi F; Deaglio S;

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.

2020
AOU Città della Salute di Torino
AOU Novara

Rossi D; Gaidano G; Foà R; Deaglio S; Catherwood M; Boldorini RL; Gattei V; Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; et alii...

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. in Haematologica / Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

2018
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Ghia P; Moreno C; Foà R; de la Serna J; Vignetti M; Kennedy B; Bowles KM; Eyre TA; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Gaidano G; Re F; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Billio A; Visco C; Amendola A; Mauro FR; Galieni P; Orlandi EM; et alii...

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.

2015
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Gaidano G; Gattei V; Foà R; Cuneo A; Montillo M; Massaia M; Zinzani PL; Del Poeta G; Perbellini O; Moreno C; Marasca R; Tedeschi A; Neri A; Motta M; Coscia M; Rigolin GM; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Morabito F; Cortelezzi A; Mauro FR; Visco C; Chiarenza A; Bulian P; Ghilardi G; et alii...